Call us to discuss our Clinical Trials: (386) 898-0547 x 6
or email
Dont Forget: Contact our research staff now about the Clinical Trial that interests you
About Us

Our Vision

Dr Matt Leavitt, the founder and medical director of Advanced Dermatology and Cosmetic Surgery (ADCS), has undertaken the challenge of establishing the largest networked clinical research group in the country. At this point, ADCS sees over 450,000 patients per year. Dr. Leavitt recognizes that never before has there been an opportunity to provide this many patients in one dermatology practice access to clinical trials. Nor has there ever been the ability to provide to those doing clinical studies the potential access to tens of thousands of dermatology patients.

Dr Leavitt has assigned James A Solomon, MD PhD, the Director of Ameriderm Research, the Research Division of ADCS, the task to achieve this goal. The plan is to recruit the entire group of over 98 providers in ADCS either to directly participate in research studies or to identify and refer patients to these studies. Several key sites throughout Florida will be established as primary research sites. Initial primary sites will include Ormond Beach, one in the Orlando area, one in Jacksonville. Others will follow as needed. The remaining offices will become satellite sites which help recruit study patients. The entire 450,000 patients will come under electronic medical records.

In addition to his role as Director of the Ameriderm Research, Dr Solomon holds academic appointments as Assistant Clinical Professor at University of Illinois College of Medicine, Urbana-Champaign (UIUC) as well as Associate Professor at University Central Florida College of Medicine (UCF). Dr Solomon is collaborating with the National Center Supercomputing Applications at UIUC to develop a multi-factorial clinical patient data base/ Electronic Medical Record that can analyze data from tens of thousands of patients. Once this is availale , the data base can greatly expand the size of NIH studies in many fields of medicine that can be done through universities. In addition, the access to such multi-factorial data will allow industry to determine what other factors may be contributing to the success or failure of their product. Ameriderm Research and the Beckman Institute for Advanced Science and Technology at UIUC are cooperating on a venture to develop a device which can display and analyze 3-D virtual in vivo dermatopathology In addition, the Ameriderm Research is developing cooperation on several other basic clinical research projects at both UIUC, UCF And Wake Forest University.

Despite that we are primarily a dermatology practice; we plan to include studies across all fields of medicine. We have cooperative relationships with family practice, allergy/immunology, and orthopedic physicians to work within our sites on clinical trials.

We look forward to working with industry and universities to achieve this medical research goal.